cefixime has been researched along with Airflow Obstruction, Chronic in 2 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brückner, O | 1 |
Trautmann, M | 1 |
Catena, E | 1 |
Mistretta, A | 1 |
Micillo, E | 1 |
Crimi, N | 1 |
Dericoloso, L | 1 |
Tranchese, D | 1 |
Barbagallo, S | 1 |
2 other studies available for cefixime and Airflow Obstruction, Chronic
Article | Year |
---|---|
Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bronchitis; Cefixime; Ciprofloxacin; Clinical Trials as | 1989 |
Cefixime: comparative clinical trial on the treatment of lower respiratory tract infection in adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchitis; Bronchopneumonia; Cefixime; Cephalexin; Clinic | 1989 |